Bridgend-based Biotec Services International has expanded its presence in Israel with the appointment of a new Israeli Agent.
Dr Kela-Madar will strengthen Biotec Services’ Business Development Team by using her broad network in the Israeli and US Biotechnology industries.
Dr Kela-Madar graduated with a PhD from the Weizmann Institute (Israel) and then went on to specialise in Drug Development at Stanford University (CA, USA), where she was awarded the McCormick Award from the Stanford School of Medicine.
Dr Kela-Madar is an expert in developing challenging markets, networks and identifying potential opportunities by analysing the scientific and business aspects.
To accompany Dr Kela-Madars arrival and strengthen its presence in Israel, Biotec Services has launched a new Israeli website, www.biotec-israel.com.
Dr Kela-Madar commented on her appointment, “I am very happy to be joining an International organisation like Biotec who has a fantastic reputation in the industry and I look forward to being part of its future success. I fully intend to make an immediate contribution to the success of the territories for which I am responsible, to create new collaborations and to promote Biotec’s range of services.”
In addition to expansion in Israel, the clinical supplies company, has appointed two new Qualified Persons (QPs) to its Quality Assurance team in the UK – Dr Shawn Murtough & Dr Susan Marlow.
Dr Murtough joins Biotec Services as a QP, previously working at Penn Pharmaceutical Service Ltd for over ten years. Dr Murtough studied both his Biotechnology degree and Pharmaceutical Microbiology PhD at Cardiff University before going on to gain his industry CMO experience at Patheon and Penn Pharmaceutical Service Ltd. Dr Murtough undertook his QP training with David Begg Associates in 2007 and is also a trained Pharmaceutical GMP & ISO 9000 Series lead auditor.
Dr Susan Marlow QP has over 16 years’ experience in the biotechnology and pharmaceutical industry with specific experience in Quality Management of IMP manufacture, testing and regulatory compliance.
Dr Shawn Murtough & Dr Susan Marlow bring the total number of QPs on Biotec Services’ licences to eight, six of whom have considerable experience with aseptically manufactured products including biopharmaceuticals and ATMPs.
Keren Winmill, Chief Executive Officer, said: “We are at a very important time in our expansion plan as we look to strengthen and grow our international presence. Israel is a key growth area for our business so we are delighted to have Dr Kela-Madar on board. Her knowledge of the industry and strong Israeli network will undoubtedly strengthen our presence in this market.
“Enhancing our QP consultancy services is also a key strategy for us as we look to grow our international client base and we’re pleased to welcome both Dr Shawn Murtough & Dr Susan Marlow who bring with them a wealth of experience in this area. They will work closely with clients from across North America, Israel, Asia and within the EC/EEA, helping to facilitate the smooth importation of IMPs into Europe for use in clinical trials both within the EC/EEA and other regions.”
Biotec Services has established itself as a truly international, trusted partner delivering clinical trials supply services with proven expertise in packaging, storing and distributing clinical and commercial supplies over a wide range of temperatures, to countries worldwide.